Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (3478)	12/3/1999 5:04:00 PM
From: Stephen M. DeMoss	Read Replies (2) \| Respond to of 4140

Kevin, Its not clear if you are short or just skeptical. I am long the company because I think the company had to have learned allot from the collapse of their stock price last time they dissapointed. I believe the reality is clear to them: put up or go out of business. They may have had incomplete data last time, but this time, they likely will have more than enough data for the FDA. I believe they will at least get conditional approval if not full approval. The stock price will rocket with either of those results. If I was short the stock, I would not sleep well. Maybe buy some puts when it moves to the 20 dollar level pre-announcement, but never short here. Last time the MM's had the opening price at 35 IF approval came. I am very long the stock but will buy some protective puts just as a hedge (no one knows the for sure outcome, supposedly<G>). I just think there are much less riskier short positions than this one. Thoughts? Steve D.